Breaking News Headlines Today | Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

NJBIZ image

News from NJBIZ

NJBIZ’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

NJBIZ’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about NJBIZ

Where is NJBIZ located?NJBIZ's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top NJBIZ News

New Jersey Declares State of Emergency as nor’easter Approaches — REUTERS / ixx511

State of Emergency · New Jersey

New Jersey Declares State of Emergency as nor’easter Approaches

60% Center coverage: 159 sources

Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case — REUTERS / ixx511

Johnson & Johnson · United States

Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case

49% Center coverage: 33 sources

A Los Angeles jury late on Monday ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest lawsuit alleging its baby powder products cause cancer.See the Story

What's Going On With Bristol Myers Squibb Stock Friday? - Bristol-Myers Squibb (NYSE:BMY)

What's Going On With Bristol Myers Squibb Stock Friday? - Bristol-Myers Squibb (NYSE:BMY)

70% Center coverage: 10 sources

Bristol Myers Squibb is acquiring Orbital Therapeutics for $1.5 billion, expanding its RNA and in vivo CAR T-cell therapy portfolio.See the Story

Breaking News Topics Related to NJBIZ